Skip to main content
. Author manuscript; available in PMC: 2008 Mar 3.
Published in final edited form as: J Neurochem. 2007 Oct 1;103(6):2462–2470. doi: 10.1111/j.1471-4159.2007.04942.x

Fig. 2.

Fig. 2

Levels of cAMP-dependent protein kinase (PKA) subunits/isoforms in Alzheimer disease (AD) and control brains. (a) Western blots of the medial temporal cortical homogenate from six AD and seven control brains, which were probed with antibodies against various subunits/isoforms of PKA, as indicated on the left of the blots. (b) Densitometric quantitation of the blots shown in panel (a). Mean ± SD of the relative immunoreactivities are shown. *p < 0.05 as compared with the control groups.